Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara White

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Genetics|August 5, 2006
Genetic analysis of slipper/mixed lineage kinase reveals requirements in multiple Jun-N-terminal kinase-dependent morphogenetic events during Drosophila developmentStephanie Polaski, Lisa Whitney, Barbara White Barker, et al.
The Journal of Rheumatology|December 17, 2003
Scleroderma patients with combined pulmonary hypertension and interstitial lung diseaseBetty Chang, Fredrick M Wigley, Barbara White, et al.
Arthritis Research & Therapy|April 16, 2010
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosusYihong Yao, Brandon W Higgs, Laura Richman, et al.
The Journal of Investigative Dermatology|June 18, 2023
Validation of Cutaneous Dermatomyositis Disease Area and Severity Index Activity Score and Other Efficacy Outcomes as Measures of Skin Disease in Dermatomyositis in the Lenabasum Phase 3 TrialRachita Pandya, Joshua Dan, Julianne Kleitsch, et al.
The Journal of Rheumatology|February 9, 2006
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in sclerodermaBetty Chang, Lionel Schachna, Barbara White, et al.
Aging Clinical and Experimental Research|January 27, 2018
The effects of a multicomponent intervention program on clinical outcomes associated with falls in healthy older adultsYoung-Hee Cho, Olfat Mohamed, Barbara White, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 29, 2025
Development and Evaluation of the Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical TrialsRachita Pandya, Joshua Dan, Julianne Kleitsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signalingSergei P Atamas, Irina G Luzina, Heqiao Dai, et al.
Annals of the Rheumatic Diseases|May 27, 2011
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human studyGerd R Burmester, Eugen Feist, Matthew A Sleeman, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 1, 2012
Fine-needle aspiration biopsy of thyroid bed lesions in post-thyroidectomy patients: what is the importance of nondiagnostic biopsy results?Chiara Zini, Stephen Thomas, Roy Raad, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Genetics|August 5, 2006
Genetic analysis of slipper/mixed lineage kinase reveals requirements in multiple Jun-N-terminal kinase-dependent morphogenetic events during Drosophila developmentStephanie Polaski, Lisa Whitney, Barbara White Barker, et al.
The Journal of Rheumatology|December 17, 2003
Scleroderma patients with combined pulmonary hypertension and interstitial lung diseaseBetty Chang, Fredrick M Wigley, Barbara White, et al.
Arthritis Research & Therapy|April 16, 2010
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosusYihong Yao, Brandon W Higgs, Laura Richman, et al.
The Journal of Investigative Dermatology|June 18, 2023
Validation of Cutaneous Dermatomyositis Disease Area and Severity Index Activity Score and Other Efficacy Outcomes as Measures of Skin Disease in Dermatomyositis in the Lenabasum Phase 3 TrialRachita Pandya, Joshua Dan, Julianne Kleitsch, et al.
The Journal of Rheumatology|February 9, 2006
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in sclerodermaBetty Chang, Lionel Schachna, Barbara White, et al.
Aging Clinical and Experimental Research|January 27, 2018
The effects of a multicomponent intervention program on clinical outcomes associated with falls in healthy older adultsYoung-Hee Cho, Olfat Mohamed, Barbara White, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 29, 2025
Development and Evaluation of the Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical TrialsRachita Pandya, Joshua Dan, Julianne Kleitsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signalingSergei P Atamas, Irina G Luzina, Heqiao Dai, et al.
Annals of the Rheumatic Diseases|May 27, 2011
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human studyGerd R Burmester, Eugen Feist, Matthew A Sleeman, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 1, 2012
Fine-needle aspiration biopsy of thyroid bed lesions in post-thyroidectomy patients: what is the importance of nondiagnostic biopsy results?Chiara Zini, Stephen Thomas, Roy Raad, et al.
Pageof 8